课题基金 / 基金详情

Deciphering mechanisms of myoblast fusion

Deciphering mechanisms of myoblast fusion
破译成肌细胞融合机制
批准号:
10818710
负责人:
Douglas Paul Millay
金额:
$24.08万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-07-01 至 2025-06-30

项目摘要

项目成果

Douglas Paul Millay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Despite the importance of myoblast fusion for normal muscle development and physiology, relatively little is known about the molecules that directly function to remodel membranes during the myoblast fusion reaction. Elucidation of fusion mechanisms is critical to fully understand muscle development and to identify novel therapeutic strategies to augment skeletal muscle disease. We previously discovered that myomaker (Mymk) and myomerger (Mymx) are essential for the fusion of skeletal muscle progenitors. Moreover, ectopic expression of these two membrane proteins induces fusion of otherwise non-fusogenic cells (fibroblasts). For the first time, this establishes a cell-based reconstitution system with myoblast fusogens, however many questions exist as to how these two proteins induce fusion. We have recently found that myomaker and myomerger drive fusion through a unique cellular mechanism, by dividing their independent membrane remodeling activities to distinctly impact the fusion process. It stands to reason that the membrane-remodeling activities of myomaker and myomerger must be highly regulated or they could have the potential to compromise cellular integrity. With this supplement, we will expand our program to identify novel factors that regulate fusion in skeletal muscle tissue. Overall, this work promises to open up a new area of investigation into the cell biology of muscle and positively impact the possibility to harness fusion to improve regenerative medicine.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s13395-017-0149-3
发表时间: 2018-01-31
期刊: Skeletal muscle
影响因子: 4.9
作者: [Sampath SC, Sampath SC, Millay DP]
通讯作者: Millay DP
DOI: 10.1016/j.devcel.2018.08.006
发表时间: 2018-09-24
期刊: Developmental cell
影响因子: 11.8
作者: [Leikina E, Gamage DG, Prasad V, Goykhberg J, Crowe M, Diao J, Kozlov MM, Chernomordik LV, Millay DP]
通讯作者: Millay DP
Myonuclear dynamics during skeletal muscle aging
  • 批准号:
    10714194
  • 项目类别:
  • 资助金额:
    $42.34万
  • 财政年份:
    2023
  • 负责人:
    Douglas Paul Millay
  • 依托单位:
Improving delivery of therapeutic material to skeletal muscle
  • 批准号:
    10022097
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2019
  • 负责人:
    Douglas Paul Millay
  • 依托单位:
Improving delivery of therapeutic material to skeletal muscle
  • 批准号:
    9906360
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2019
  • 负责人:
    Douglas Paul Millay
  • 依托单位:
Improving delivery of therapeutic material to skeletal muscle
  • 批准号:
    10617940
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2019
  • 负责人:
    Douglas Paul Millay
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: